share_log

Assure | 8-K: Current report

Assure | 8-K: Current report

Assure | 8-K：重大事件
美股sec公告 ·  05/08 12:50
Moomoo AI 已提取核心信息
On May 6, 2024, Assure Holdings Corp. (NASDAQ: IONM), a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company has already received a favorable response, with over 95% of votes cast supporting the proposal. However, more votes are needed to reach the required 50% of outstanding shares for approval. CEO John Farlinger emphasized the importance of each vote, including those from stockholders with smaller positions. The increase in authorized shares is deemed critical for the company's capital needs. Assure has filed a definitive proxy statement with the SEC, and the documents are available on both the company's and SEC's websites. The proposed increase is part of a larger transaction with Danam Health Inc., which includes a merger and the combined company's listing on Nasdaq. The transaction is subject to stockholder approval and other customary closing conditions.
On May 6, 2024, Assure Holdings Corp. (NASDAQ: IONM), a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company has already received a favorable response, with over 95% of votes cast supporting the proposal. However, more votes are needed to reach the required 50% of outstanding shares for approval. CEO John Farlinger emphasized the importance of each vote, including those from stockholders with smaller positions. The increase in authorized shares is deemed critical for the company's capital needs. Assure has filed a definitive proxy statement with the SEC, and the documents are available on both the company's and SEC's websites. The proposed increase is part of a larger transaction with Danam Health Inc., which includes a merger and the combined company's listing on Nasdaq. The transaction is subject to stockholder approval and other customary closing conditions.
2024年5月6日，术中神经监测和远程神经病学服务提供商Assure Holdings Corp.（纳斯达克股票代码：IONM）发布了一份新闻稿，敦促其股东对将授权普通股数量从900万股增加到2.5亿股的提议投赞成票。股东特别会议定于2024年5月14日举行。该公司已经获得了积极的回应，超过95％的选票支持该提案。但是，需要更多的选票才能获得批准所需的50％的已发行股份。首席执行官约翰·法林格强调了每一次投票的重要性，包括来自持仓较小的股东的投票。法定股票的增加被认为对公司的资本需求至关重要。Assure已向美国证券交易委员会提交了最终的委托书，这些文件可在该公司和美国证券交易委员会的网站上查阅。拟议的增幅是与达南健康公司进行的大规模交易的一部分，其中包括合并和合并后的公司在纳斯达克上市。该交易须经股东批准和其他惯例成交条件。
2024年5月6日，术中神经监测和远程神经病学服务提供商Assure Holdings Corp.（纳斯达克股票代码：IONM）发布了一份新闻稿，敦促其股东对将授权普通股数量从900万股增加到2.5亿股的提议投赞成票。股东特别会议定于2024年5月14日举行。该公司已经获得了积极的回应，超过95％的选票支持该提案。但是，需要更多的选票才能获得批准所需的50％的已发行股份。首席执行官约翰·法林格强调了每一次投票的重要性，包括来自持仓较小的股东的投票。法定股票的增加被认为对公司的资本需求至关重要。Assure已向美国证券交易委员会提交了最终的委托书，这些文件可在该公司和美国证券交易委员会的网站上查阅。拟议的增幅是与达南健康公司进行的大规模交易的一部分，其中包括合并和合并后的公司在纳斯达克上市。该交易须经股东批准和其他惯例成交条件。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息